$87.82
+21.62 (+32.66%)
Open$74.55
Previous Close$66.20
Day High$93.53
Day Low$74.55
52W High$97.97
52W Low$4.02
Volume—
Avg Volume32.5K
Market Cap227.63M
P/E Ratio—
EPS$-3.23
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
-85.9% upside
Current
$87.82
$87.82
Target
$12.40
$12.40
$7.31
$12.40 avg
$17.49
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 11.93M | 16.64M | 80.43M |
| Net Income | -10,940,309 | -13,728,775 | 27.17M |
| Profit Margin | -91.7% | -87.1% | 33.8% |
| EBITDA | -12,182,145 | -16,136,416 | 38.14M |
| Free Cash Flow | — | — | 15.33M |
| Rev Growth | -28.3% | -28.3% | -4.6% |
| Debt/Equity | — | — | 0.36 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |